Overview

PRO With Luxerm® in the Field Treatment of Thin and Non-hyperkeratotic Non-pigmented AK

Status:
Completed
Trial end date:
2017-11-28
Target enrollment:
Participant gender:
Summary
Interventional open label prospective and multicentre study conducted in Germany in subjects with thin or non-hyperkeratotic and non-pigmented multiple AKs in one anatomical area on the face (e.g., forehead or cheek or chin), excluding nose eyelids, lips and mucosa or balding scalp, using Luxerm® DL-PDT treatment.
Phase:
Phase 4
Details
Lead Sponsor:
Galderma
Galderma R&D
Collaborator:
GCP services
Treatments:
Aminolevulinic Acid
Methyl 5-aminolevulinate